We deliver the latest domestic and international trends in the medical device industry. This report summarizes the forefront of technological innovation aimed at solving challenges in medical settings, including the approval of AI-powered next-generation imaging technology, expanded indications for surgical robots, and the latest regulatory clearances for surgical devices.
1. Abbott Receives FDA Clearance and CE Mark for AI-Powered Next-Generation Coronary Imaging Platform "Ultreon 3.0"
Abbott announced that it has received U.S. Food and Drug Administration (FDA) clearance and the European CE Mark for its next-generation AI-powered coronary imaging platform, "Ultreon 3.0" [1]. This medical device integrates AI into an optical coherence tomography (OCT) system, providing physicians with real-time, high-resolution visualization of plaque (lesions) within blood vessels when treating complex coronary artery disease. By using AI to suggest optimal stent size and placement, it is expected to support faster and more accurate decision-making, contributing to improved patient outcomes.
2. Olympus Receives FDA Approval for Surgical Device "POWERSEAL Open Extended Jaw"
Olympus has received FDA 510(k) clearance for its advanced bipolar energy device for open surgery, "POWERSEAL Open Extended Jaw" [2]. This device is designed to reliably seal and cut vessels and tissue bundles up to 7mm. Its ergonomic design reduces surgeon hand fatigue, improving efficiency and comfort in the operating room. A full market launch is planned for late spring 2026, further strengthening the company's portfolio of surgical energy devices.
3. CMR Surgical Submits FDA Application to Expand Indications of Surgical Robot "Versius Plus" to Gynecology
UK-based CMR Surgical has submitted a 510(k) premarket notification to the U.S. FDA for its modular surgical robot, "Versius Plus" [3]. This regulatory application aims to expand the indications to include surgeries for benign gynecological conditions such as hysterectomies and oophorectomies. While already widely used in gynecology outside the U.S., this is a crucial step to provide more healthcare facilities and patients with minimally invasive surgical options in the U.S., the world's largest market for surgical robots.
4. Domestic Regulatory Trends: Evolution of AI Medical Devices and PMDA's Response
As the development of AI-powered image diagnostic support systems accelerates globally, the introduction of AI-assisted reading technology for gastrointestinal endoscopy and chest X-rays is also progressing in Japan. In response to such technological innovations, PMDA (Pharmaceuticals and Medical Devices Agency) is working to establish a rapid and flexible review process for medical devices as software (SaMD). In particular, the development of a new regulatory framework that considers the characteristic of AI to improve performance through data accumulation in clinical settings is key to delivering the latest technology safely and quickly to patients.
References
[1] Abbott. "Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform." April 28, 2026. https://abbott.mediaroom.com/2026-04-28-Abbott-receives-FDA-clearance-and-CE-Mark-for-next-generation-Ultreon-TM-3-0-AI-powered-coronary-imaging-platform [2] MassDevice. "Olympus wins FDA clearance for Powerseal open extended jaw device." April 28, 2026. https://www.massdevice.com/olympus-fda-clearance-powerseal-jaw-sealer-divider/ [3] Surgical Robotics Technology. "CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™." April 29, 2026. https://www.surgicalroboticstechnology.com/news/cmr-surgical-submits-510k-application-to-u-s-fda-to-expand-versius-plus/
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation